Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: cannabidiol
Trade Name: Epidiolex
Date Designated: 04/19/2016
Orphan Designation: Treatment of tuberous sclerosis complex.
Orphan Designation Status: Designated/Approved
GW Research Ltd.
Sovereign House
Histon
Cambridge
United Kingdom

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: cannabidiol
Trade Name: Epidiolex
Marketing Approval Date: 07/31/2020
Approved Labeled Indication: treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients 1 year of age and older
Exclusivity End Date: 07/31/2027 
Exclusivity Protected Indication* :   treatment of seizures associated with tuberous sclerosis complex (TSC) in patients 1 year of age and older
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-